Prophylactic treatment with the nucleoside analogue 2'-C-methylcytidine completely prevents transmission of norovirus

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 1, 2015, Pages 190-197

  Rocha Pereira, J ^a   Jochmans, D ^a   Neyts, J ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antiviral drugs; Control and prevention; Diarrhoea; Mouse model; Outbreak

Indexed keywords

2' METHYLCYTIDINE; VIRUS RNA; 2'-C-METHYLCYTIDINE; ANTIVIRUS AGENT; CYTIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DISEASE DURATION; FECES ANALYSIS; FEMALE; GENERAL CONDITION; MALE; MOUSE; NONHUMAN; NOROVIRUS INFECTION; PROPHYLAXIS; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TRANSMISSION; WEIGHT REDUCTION; WEIGHT VARIATION; ANALOGS AND DERIVATIVES; ANIMAL; CALICIVIRIDAE INFECTIONS; CHEMOPROPHYLAXIS; DISEASE MODEL; DRUG EFFECTS; NOROVIRUS; PROCEDURES; SURVIVAL;

ANIMALS; ANTIVIRAL AGENTS; CALICIVIRIDAE INFECTIONS; CHEMOPREVENTION; CYTIDINE; DIARRHEA; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; NOROVIRUS; SURVIVAL ANALYSIS;

EID: 84928333094     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku363     Document Type: Article

References (20)

1. Kroneman A, Verhoef L, Harris J et al. Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006. J Clin Microbiol 2008; 46: 2959-65.
2. Scallan E, Hoekstra RM, Angulo FJ et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011; 17: 7-15.
3. Vega E, Barclay L, Gregoricus N et al. Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013. J Clin Microbiol 2014; 52: 147-55.
4. Harris JP, Adams NL, Lopman BA et al. The development of web-based surveillance provides new insights into the burden of norovirus outbreaks in hospitals in England. Epidemiol Infect 2014; 142: 1590-8.
5. Lopman BA, Hall AJ, Curns AT et al. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin Infect Dis 2011; 52: 466-74.
6. Bok K, Green KY. Norovirus gastroenteritis in immunocompromised patients. New Engl J Med 2012; 367: 2126-32.
7. Patel MM, Widdowson MA, Glass RI et al. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 2008; 14: 1224-31.
8. Green KY. Caliciviridae: the noroviruses. In: Knipe DM, Howley PM, eds. Fields Virology. Philadelphia, PA: Lippincott Williams & Wilkins, 2013; 583-609.
9. Rodríguez-Lázaro D, Cook N, Ruggeri FM et al. Virus hazards from food, water and other contaminated environments. FEMS Microbiol Rev 2012; 36: 786-814.
10. Karst SM, Wobus CE, Lay M et al. STAT1-dependent innate immunity to a Norwalk-like virus. Science 2003; 299: 1575-8.
11. Wobus CE, Karst SM, Thackray LB et al. Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol 2004; 2: e432.
12. Rocha-Pereira J, Jochmans D, Dallmeier K et al. Inhibition of norovirus replication by the nucleoside analogue 2'-C-methylcytidine. Biochem Biophys Res Commun 2012; 427: 796-800.
13. Rocha-Pereira J, Jochmans D, Debing Y et al. The viral polymerase inhibitor 2'-C-methylcytidine inhibits Norwalk virus replication and protects against norovirus-induced diarrhea and mortality in a mouse model. J Virol 2013; 87: 11798-805.
14. Pierra C, Amador A, Benzaria S et al. Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine. J Med Chem 2006; 49: 6614-20.
15. Rocha-Pereira J, Jochmans D, Dallmeier K et al. Favipiravir (T-705) inhibits in vitro norovirus replication. Biochem Biophys Res Commun 2012; 424: 777-80.
16. Chachu KA, Strong DW, LoBue AD et al. Antibody is critical for the clearance of murine norovirus infection. J Virol 2008; 82: 6610-7.
17. Atmar RL, Opekun AR, Gilger MA et al. Norwalk virus shedding after experimental human infection. Emerg Infect Dis 2008; 14: 1553-7.
18. Siebenga JJ, Beersma MF, Vennema H et al. High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution. J Infect Dis 2008; 198: 994-1001.
19. Teunis PF, Moe CL, Liu P et al. Norwalk virus: how infectious is it?. J Med Virol 2008; 80: 1468-76.
20. Lopman B, Gastanaduy P, ParkG W et al. Environmental transmission of norovirus gastroenteritis. Curr Opin Virol 2012; 2: 96-102.